Methocarbamol

美索巴莫

Report date: 2023/02/22 20:00:32
NME

Base Information

Drug NameMethocarbamol
Drug Alias Name舒筋灵Methocarbamolum每弛卡摩MiolaxeneNeuraxin +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrase I inhibitors
TargetsCarbonic anhydrase I
Therapy Area/IndicationsLiver CirrhosisMyalgiaMusculoskeletal Pain +[4] 
Global Approved IndicationsMusculoskeletal PainMuscle Spasticity
Approved Indications in ChinaMusculoskeletal PainMuscle Spasticity
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesEgyptEU +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEndo International Plc
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdHikma Pharmaceuticals PlcNanjing Baijingyu Pharmaceutical Co Ltd
Inactive CompaniesEndo Operations LtdTanta University
Active IndicationsMyalgiaMusculoskeletal PainMuscle Spasticity
Inactive IndicationsLiver Cirrhosis

Other Information

ATC CodeM03BA03
Related LinksWikipediaDrugBankKEGG